In today's journal club, we discussed a recent contribution from Michael Zimmermann's group @embl.org, Heidelberg, available on bioRxiv.
Neat work illustrating the potential of individual members of the gut microbiome in drug-prodrug transformation impacting PK.
www.biorxiv.org/content/10.6...
